Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 67Colorectal Neoplasms 36Central Nervous System Neoplasms 36Colonic Neoplasms 34Rectal Neoplasms 32Glioblastoma 23Gliosarcoma 20Carcinoma, Non-Small-Cell Lung 20Lung Neoplasms 18Stomach Neoplasms 16Pancreatic Neoplasms 15Sarcoma 14Ovarian Neoplasms 13Head and Neck Neoplasms 13Prostatic Neoplasms 12Squamous Cell Carcinoma of Head and Neck 11Neoplasm Metastasis 11Melanoma 11Astrocytoma 11Esophageal Neoplasms 10Carcinoma, Ovarian Epithelial 10Brain Neoplasms 10Uterine Cervical Neoplasms 9Kidney Neoplasms 9Fallopian Tube Neoplasms 9Carcinoma, Intraductal, Noninfiltrating 9Breast Carcinoma In Situ 9Breast Neoplasms, Male 8Adenocarcinoma Of Esophagus 8Liver Neoplasms 7

Interventions

Doxorubicin 9Imatinib Mesylate 6pazopanib 4Ifosfamide 4Radiotherapy 3Gemcitabine 3Docetaxel 3pembrolizumab 2Radiation 2Neoadjuvant Therapy 2Biopsy 23-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 2selinexor 1saracatinib 1sapanisertib 1ribociclib 1peposertib 1liposomal doxorubicin 1indolepropanol phosphate 1envafolimab 1cixutumumab 1brigimadlin 1avelumab 1X-Rays 1Watchful Waiting 1TTI-621 1Sunitinib 1Specimen Handling 1Razoxane 1Radiotherapy, Intensity-Modulated 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Dermatofibrosarcoma × Chemotherapy, Adjuvant × Clear all
NCT00334854 2013-08-12

Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma

National Cancer Institute (NCI)

Phase 3 Unknown
250 enrolled
Sarcoma

Hemangiopericytoma, Malignant, Chondrosarcoma, Fibrosarcoma, Hemangiosarcoma, Liposarcoma, Sarcoma, Dermatofibrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡